Business
Johnson & Johnson and three large drug distributors said Friday that opioid settlements worth nearly $25 billion.
Hi, what are you looking for?
Johnson & Johnson and three large drug distributors said Friday that opioid settlements worth nearly $25 billion.
The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis.
US manufacturer 3M warned Monday that demand is expected to slow sharply this year.
British Covid vaccine maker AstraZeneca said that net profit collapsed last year, hit by the vast takeover of US biotech firm Alexion.
Johnson & Johnson has temporarily suspended production at a key plant manufacturing the Covid-19 vaccine, the NYTimes reported.
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic.
Pfizer expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid Native Americans' addiction.
Consumer goods giant Unilever said it would not increase a £50-billion offer for pharmaceutical groups GlaxoSmithKline and Pfizer.
The European Medicines Agency said Tuesday it had started a "rolling review" of France's Sanofi coronavirus jab.